Policy & Regulation

On February 25, 2025, the U.S. Food and Drug Administration (FDA) announced an adjustment to the final rule regarding the definition of the term "healthy" in food labeling, as detailed in the Federal Register.

• ECHEMI high quality inquiries

The European Union is on the brink of a significant transformation in its biopesticide regulations, aimed at expediting the approval process for biopesticides and biocontrol products.

The Indian pharmaceutical industry is making significant strides on the global stage, having overtaken U.S. counterparts with 752 FDA-registered manufacturing sites.

India's contract drug manufacturers are calling for urgent government assistance to overcome regulatory challenges and enhance their competitiveness against China.

• ECHEMI high quality inquiries

On February 24, 2025, the European Commission released a new regulation that introduces 12 significant amendments to existing food additive policies, marking a crucial development for the food industry in Europe.

In a significant legal challenge, drug compounders have sued the U.S. Food and Drug Administration (FDA) over its recent decision to remove Wegovy and Ozempic from the official shortage list.

The global clean label ingredients market is on track for remarkable growth, projected to reach USD 57.3 billion by 2025 and expand at a 15.5% CAGR to hit USD 212.4 billion by 2035.

In response to the growing need for consumer safety and product quality, the State Administration for Market Regulation issued Announcement No. 9 last year regarding the mandatory certification management of commercial gas burners and other products.

In a significant move, Kyle Diamantas, a prominent attorney with extensive experience in food regulation, has been appointed as the new top food regulator at the FDA.

On February 3, 2025, Panama's President Jose Raul Mulino announced the country’s decision to withdraw from the Belt and Road Initiative (BRI), which could be seen as a significant geopolitical shift.

On February 18, 2025, Chemours announced a strategic review of its Advanced Performance Materials (APM) business in Europe following the release of its 2024 financial results.

• ECHEMI high quality inquiries

The U.S. Food and Drug Administration (FDA) is under increasing scrutiny following the recent approval of several new drugs, raising concerns regarding their safety and efficacy.

In a surprising move, Jim Jones, the head of the Food and Drug Administration’s (FDA) food safety division, has announced his resignation.

The instant noodles market is projected to skyrocket to $99.8 billion by 2032, according to recent industry analysis.

On the evening of February 15, the U.S. government announced layoffs affecting several employees at the FDA. The exact number of affected staff and the specific departments involved remain unclear.

The U.S. Food and Drug Administration has updated its recall for over 2 million cases of MadeGood granola bars due to potential metal contamination.

The European Union has introduced significant updates to its Health Technology Assessment (HTA) regulations, aiming to accelerate drug access for patients across member states.